Comparison between Dar Credit IPO and Sheel Biotech IPO.
Dar Credit IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sheel Biotech IPO is a SME Fixed Price proposed to list at NSE SME.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | SMC Global Securities Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Dar Credit IPO is up to ₹24.36 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹0.00 Cr. The final issue price of Dar Credit IPO is ₹60.00 per share and of Sheel Biotech IPO is .
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹57.00 per share | |
| Issue Price (Upper) | ₹60.00 per share | |
| Issue Price (Final) | ₹60.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 40,60,000 shares | 54,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹24.36 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 40,60,000 shares | 54,00,000 shares |
| Issue Size Total (Amount) | up to ₹24.36 Cr | up to ₹0.00 Cr |
Dar Credit IPO opens on May 21, 2025, while Sheel Biotech IPO opens on . The closing date of Dar Credit IPO and Sheel Biotech IPO is May 23, 2025, and , respectively.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | May 20, 2025 | |
| Issue Open | May 21, 2025 | |
| Issue Close | May 23, 2025 | |
| Basis Of Allotment (Tentative) | May 26, 2025 | |
| Initiation of Refunds (Tentative) | May 27, 2025 | |
| Credit of Share (Tentative) | May 27, 2025 | |
| Listing date (Tentative) | May 28, 2025 | |
| Anchor Lockin End date 1 | Jun 25, 2025 | |
| Anchor Lockin End date 2 | Aug 24, 2025 |
Dar Credit IPO P/E ratio is 15.12, as compared to Sheel Biotech IPO P/E ratio of .
| Dar Credit IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Dar Credit and Capital Limited Financial Information (Restated Standalone)
| Sheel Biotech Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.47 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹85.66 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.17% | 14.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 9.22% | 16.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.51 | 0.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.08% | 14.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dar Credit IPO Retail Individual Investors (RII) are offered 14,22,000 shares while in Sheel Biotech IPO retail investors are offered 14,22,000 shares. Qualified Institutional Buyers (QIB) are offered 8,12,000 shares in Dar Credit IPO and in Sheel Biotech IPO.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | 12,16,000 shares | |
| Market Maker Reserveration | 2,16,000 shares | 2,73,600 shares |
| QIB | 8,12,000 shares | |
| NII | 6,10,000 shares | |
| RII | 14,22,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 40,60,000 shares |
Dar Credit IPO subscribed 106.09x in total, whereas Sheel Biotech IPO subscribed .
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 31.29x | |
| NII (times) | 208.45x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 104.88x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 106.09x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
